Screener
Theravance Biopharma TBPH Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Theravance Biopharma’s reported figures.
The source filing: Theravance Biopharma’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 9:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056760
FAQ
- What is Theravance Biopharma's net debt?
- Theravance Biopharma (TBPH) reported net debt of -$247.6M in Q1 2026.
- How has Theravance Biopharma's net debt changed year-over-year?
- Theravance Biopharma's net debt decreased by 296.4% year-over-year, from -$62.46M to -$247.6M.
- What is the long-term trend for Theravance Biopharma's net debt?
- Over 5 years (2020 to 2025), Theravance Biopharma's net debt has grown at a 38.7% compound annual growth rate (CAGR), from -$24.38M to -$125.1M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Theravance Biopharma's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude